Posted inHealth
AbbVie Nears $20bn Bet on Cancer Biotech as Deal Talks Lift Revolution Shares
Healthcare M&A Written by Sarah Mitchell A potential acquisition of Revolution Medicines would deepen AbbVie’s oncology push and mark one of the largest biotech deals in years. AbbVie is in…







